A new study indicates that bariatric surgery can have positive health results on people who have insulin-treated type 2 diabetes. Diabetics who have undergone bariatric surgery have been studied before, but this study looks at the most severest of diabetics: those who require insulin.
More than 5,000 patients participated in the study, which found that many ceased taking insulin after undergoing bariatric surgery. Of the insulin-treated type 2 diabetes patients who had Roux-en-Y gastric bypass surgery (RYGB), 62 percent ended their insulin intake one year after surgery. Researchers noted the likelihood of patients who had a laparoscopic adjustable gastric banding (LAGB) to cease using insulin was 34 percent. In addition, the study found that 50.3 percent and 19.3 percent of RYGB and LAGB patients respectively saw clinical remission of diabetes after surgery.
“The present data lead to several important conclusions: that advanced type 2 diabetes is amenable to remission by bariatric surgery, that many of those who do not achieve remission no longer require insulin postoperatively and that RYGB appears to be superior to LAGB for its ability to improve metabolic parameters in this patient subset,” wrote the study’s authors.
If you are interested in weight loss surgery, check out MBL’s Ultimate Guide To Weight Loss surgery.
